Expression of cytokeratins 7 and 20 in ovarian neoplasia

American Journal of Clinical Pathology

Volumn 117, Issue 6, 2002, Pages 944-951

  Cathro, Helen P ^a   Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cytokeratin immunohistochemistry; Neoplasm; Ovarian; Ovary

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FEMALE GENITAL TRACT TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE TUMOR; MAJOR CLINICAL STUDY; OVARY METASTASIS; OVARY TUMOR; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; STAINING;

ADENOCARCINOMA, MUCINOUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; OVARIAN NEOPLASMS;

EID: 0036264553     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/2T1Y-7BB7-DAPE-PQ6L     Document Type: Article

References (35)

1. Surface epithelial-stromal tumors of the ovary
2. Primary ovarian mucinous cystadenocarcinomas: A clinicopathologic study of 49 cases with long-term follow up
3. Secondary ovarian neoplasia: A clinicopathologic study of 35 cases
4. Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma: A clinicopathologic study of 25 cases
5. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinomas and secretory endometrioid carcinoma: A clinicopathologic and immunohistochemicaI study of five cases
6. Necrosis in 84 ovarian carcinomas: A morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen
7. Metastatic ovarian tumors: Still a challenge
8. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast and ovary
9. MUC2 gene suppression in human colorectal carcinomas and their metastases: In vitro evidence of the modulatory role of DNA methylation
10. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma
11. Mucin gene expression in ovarian cancers
12. Mucin gene transcripts in benign and borderline mucinous tumors of the ovary; an in situ hybridization study
13. Can CK7/CK20 cytokeratin and MUC2/MUC5AC mucin immunohistochemistry predict the primary site of pseudomyxoma peritonei in women
14. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma
15. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma
16. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnoses between colonic and ovarian carcinomas as primary sites
17. Cytokeratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary
18. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
19. Cytokeratin 20 in human carcinomas
20. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas
21. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases
22. Cytokeratins 7, 17 and 20 reactivity in pancreatic and ampulla of Vater adenocarcinomas
23. The applicability of keratin 7 monoclonal antibody in routinely Papanicolaoustained cytologic specimens for the differential diagnosis of carcinomas
24. Keratin 20: Immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas
25. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women
26. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: Histogenetic implications of cytokeratin expression
27. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary
28. The morphologic spectrum of ovarian metastases of appendiceal carcinomas: A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other sites
29. Expression of cytokeratin 7 in simultaneous mucinous tumors of ovary and appendix
30. Cytokeratin 7 expression in rectal adenocarcinoma
31. On the use of cytokeratins 7 and 20 in the differentiation between transitional cell carcinoma and prostatic adenocarcinoma
32. On the use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas
33. Expression of cytokeratin-20 in endometrial carcinoma
34. Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: New expression of cytokeratin 20